Inventor
ATKINS ANNETTE
US11 patents
Patents
11 patentsUS9925241B2Mar 27, 2018
Mutated fibroblast growth factor (FGF) 1 and methods of use
SALK INST FOR BIOLOGICAL STUDI6 citations83
US11376264B2Jul 5, 2022
Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment
SALK INST FOR BIOLOGICAL STUDI3 citations71
US10301268B2May 28, 2019
Analogs of fexaramine and methods of making and using
SALK INST FOR BIOLOGICAL STUDI4 citations71
US9925243B2Mar 27, 2018
Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use
SALK INST FOR BIOLOGICAL STUDI5 citations69
US10695404B2Jun 30, 2020
Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs
SALK INST FOR BIOLOGICAL STUDI1 citations62
US11440889B2Sep 13, 2022
Analogs of fexaramine and methods of making and using
SALK INST FOR BIOLOGICAL STUDI0 citations61
US11760977B2Sep 19, 2023
Compositions and methods for organoid generation and disease modeling
SALK INST FOR BIOLOGICAL STUDI0 citations58
US11685901B2Jun 27, 2023
Compositions and methods for organoid generation and disease modeling
SALK INST FOR BIOLOGICAL STUDI1 citations58
US11542309B2Jan 3, 2023
Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
SALK INST FOR BIOLOGICAL STUDI0 citations58
US10815203B2Oct 27, 2020
Analogs of fexaramine and methods of making and using
SALK INST FOR BIOLOGICAL STUDI0 citations50
US10450277B2Oct 22, 2019
Analogs of fexaramine and methods of making and using
SALK INST FOR BIOLOGICAL STUDI0 citations50